Germany's health ministry has approached the military for help in ensuring safe storage of potential vaccines against COVID-19, a spokesman for the defence ministry in Berlin said on Tuesday.

BioNTech SE (NASDAQ:BNTX) shares rose 2.9% on Monday after the German biotech firm reported third-quarter revenue that far exceeded expectations, even though it posted a loss where analysts had ...

Pfizer has axed 11 programs, including two pipeline assets from its $43 billion Seagen acquisition, work on a ...

BioNTech hopes its purchase of CureVac will help boost its research into cancer treatments - Copyright AFP Sam PANTHAKY BioNTech hopes its purchase of CureVac will ...

BERLIN, Oct 30 (Reuters) - BioNTech (22UAy.F), opens new tab, Chief Executive Ugur Sahin expects efficacy results from its late-stage trial of its potential coronavirus vaccine to be available shortly ...

BioNTech and Bristol will evenly split the costs of developing and commercializing BNT327, and will "work jointly to broaden and accelerate the development of this clinical candidate." The drug is ...

BioNTech is losing its chief strategy officer, with Ryan Richardson set to leave the company at the end of September to "pursue new professional opportunities." Richardson joined BioNTech in 2018 and ...

BioNTech, the German biotech that partnered with Pfizer to develop the first COVID-19 vaccine to earn the FDA’s emergency use authorization, is now using mRNA to tackle another disease: malaria. The ...

Germany's BioNTech is buying domestic rival CureVac for $1.25 billion, the companies said Thursday, bringing together two pharmaceutical firms specialised in mRNA technology with the goal of advancing ...